Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans

Blood

Volumn 97, Issue 3, 2001, Pages 785-791

  Sawano, Asako ^b   Iwai, Shinobu ^b   Sakurai, Yoshiko ^b   Ito, Mikito ^b   Shitara, Kenya ^b   Nakahata, Tatsutoshi ^b   Shibuya, Masabumi ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STEM CELL; VASCULAR ENDOTHELIUM;

EID: 0035254646     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.3.785     Document Type: Article

References (38)

1. Mechanism of angiogenesis
2. The biology of vascular endothelial growth factor
3. Role of VEGF-Flt receptor system in normal and tumor angiogenesis
4. Structure and function of VEGF receptor-1 and -2
5. Endothelial receptor tyrosine kinases involved in angiogenesis
6. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues
7. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1)
8. The 230kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLCγ pathway and partially induces mitotic signals in NIH3T3 fibroblasts
9. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells
10. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
11. A novel type of vascular endothelial growth factor: VEGF-E (NZ-7 VEGF) preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain
12. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
13. Different signal trsnsduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
14. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor (PIGF), which is related to vascular endothelial growth factor (VEGF)
15. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
16. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
17. The vascular endothelial growth factor receptor Flt-1 mediates biological activities
18. Migration of human monocytes in response to vascular endothelilal growth factor (VEGF) is mediated via the VEGF receptor flt-1
19. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF
20. Characterization of the extracellular domain in the vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase)
21. Mapping of the sites involved in ligand-association and dissociation at the extracellular domain of vascular endothelial growth factor receptor KDR
22. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93
23. Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derived stromal cell lines
24. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
25. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
26. + cells
27. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade
28. Mapping of the sites for Iigand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1
29. + cells
30. VEGF couples hypertrophic cartilage remodeling, ossification and angiegenesis during endochondral bone formation
31. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption
32. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family
33. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
34. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth
35. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells
36. A cyclic AMP response element and an ETS motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (VEGF receptor 1) gene
37. The phosphorylated 1169-tyrosine containing region of Flt-1 kinase (VEGFR-1) is a major binding site for PLCγ